INGN Inogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INGN

Price (delayed)

$5.61

Market cap

$148.88M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.91

Enterprise value

$76.1M

?
Relative Growth: Rel. Growth: 28
Relative Strength: Rel. Strength: 19
Relative Valuation: Rel. Valuation: 35
Relative Profitability: Rel. Profitability: 29

Inogen, Inc. is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative ...

Highlights
The debt has declined by 17% year-on-year and by 7% since the previous quarter
Inogen's EPS has increased by 14% YoY
The quick ratio has contracted by 14% from the previous quarter and by 11% YoY
The equity has declined by 12% year-on-year and by 4.4% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inogen.com
Peers: ELMD RMD

Key stats

What are the main financial stats of INGN

INGN stock price

How has the Inogen stock price performed over time
Intraday
0.18%
1 week
-2.43%
1 month
-12.75%
1 year
-25.5%
YTD
-16.52%
QTD
-13.02%

Financial performance

How have Inogen's revenue and profit performed over time
Revenue
$354.3M
Gross profit
$157.69M
Operating income
-$30.85M
Net income
-$24.6M
Gross margin
44.5%
Net margin
-6.9%
The operating margin has grown by 9% YoY and by 4.4% from the previous quarter
The net margin has grown by 9% year-on-year and by 2.8% since the previous quarter
Inogen's net income has increased by 6% YoY
INGN's operating income is up by 6% year-on-year and by 3.2% since the previous quarter

Price vs fundamentals

How does INGN's price correlate with its fundamentals

Growth

What is Inogen's growth rate over time

Valuation

What is Inogen stock price valuation
P/E
N/A
P/B
0.87
P/S
0.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.21
Inogen's EPS has increased by 14% YoY
INGN's P/B is 28% below its 5-year quarterly average of 1.2 and 13% below its last 4 quarters average of 1.0
The equity has declined by 12% year-on-year and by 4.4% since the previous quarter
The stock's price to sales (P/S) is 57% less than its 5-year quarterly average of 1.0 and 14% less than its last 4 quarters average of 0.5
The revenue has increased by 3.2% year-on-year

Efficiency

How efficient is Inogen business performance
INGN's ROIC is up by 12% YoY
Inogen's ROS has increased by 9% YoY and by 2.7% from the previous quarter
Inogen's return on equity has increased by 4.3% YoY but it has decreased by 2.3% QoQ

Dividends

What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INGN.

Financial health

How did Inogen financials performed over time
INGN's total assets is 158% greater than its total liabilities
The quick ratio has contracted by 14% from the previous quarter and by 11% YoY
The company's current ratio fell by 12% QoQ and by 10% YoY
The debt is 91% smaller than the equity
The debt has declined by 17% year-on-year and by 7% since the previous quarter
The equity has declined by 12% year-on-year and by 4.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.